Remarkably, 55.5 [42.9–69.2] % of all EV aggregates (CD41+CD45+) in COVID-19 patients co-expressed TF, while the percentage of TF+ EV aggregates remained below the detection limit in healthy donors (Figure 4, middle panel). The gene discussed is ITGA2B; the disease is COVID-19.